Evolent Health, Inc. Income Statement
EVH|11 years of annual SEC 10-K data (FY2015-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 11 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$484M
FY2025
Gross Profit
N/A
FY2025
Operating Income
-$410M
FY2025
Net Income
-$65M
FY2025
Evolent Health, Inc. reported $484M in revenue and $65M in net loss for FY2025. Revenue has grown at a 17.4% compound annual rate over the past 10 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Negative return on equity: -15.6% ROE
- High leverage: Debt-to-equity ratio of 2.34
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $483.6M | $2.6B | $2.0B | $297.1M | $215.1M | $924.6M | $687.1M | $627.1M | $434.9M | $254.2M | $96.9M |
| Cost of Revenue | $1.5B | $2.2B | $1.5B | $1.0B | $657.6M | - | - | - | - | - | - |
| SG&A Expense | $303.9M | $263.1M | $358.1M | $269.3M | $219.5M | $210.4M | $236.4M | $235.4M | $205.7M | $160.7M | $75.3M |
| R&D Expense | - | - | - | - | $15.5M | $15.1M | $19.8M | $18.2M | $17.2M | $11.1M | $5.8M |
| Operating Income | -$410.1M | -$40.5M | -$71.2M | $3.6M | -$42.4M | -$262.8M | -$308.9M | -$47.5M | -$72.8M | -$237.4M | -$43.0M |
| Interest Expense | - | - | $54.2M | $15.6M | $25.4M | $28.3M | $14.6M | $5.5M | $3.6M | $247.0K | $0 |
| Income Tax | -$126.0K | -$1.4M | -$89.4M | -$43.4M | $483.0K | -$2.4M | -$22.8M | $40.0K | -$6.6M | -$10.8M | $23.5M |
| Net Income | -$64.6M | -$61.6M | -$113.0M | -$19.2M | -$37.6M | -$334.2M | -$302.0M | -$52.7M | -$60.7M | -$159.7M | $332.5M |
| EPS (Basic) | -$1.28 | -$0.20 | -$0.44 | -$3.94 | -$3.67 | - | - | - | $13.14 | -$13.46 | $2.51 |
| EPS (Diluted) | -$1.28 | -$0.20 | -$0.44 | -$3.94 | -$3.67 | -$0.68 | -$0.94 | -$3.55 | $6.93 | -$13.46 | $0.99 |
| Shares Outstanding | 111.3M | 93.7M | 86.1M | 84.9M | 82.4M | 77.3M | 64.4M | 45.0M | 46.1M | 2.3M | 3.0M |
| Operating Margin | -84.8% | -1.6% | -3.6% | 1.2% | -19.7% | -28.4% | -45.0% | -7.6% | -16.8% | -93.4% | -44.4% |
| Profit Margin | -13.4% | -2.4% | -5.8% | -6.5% | -17.5% | -36.1% | -44.0% | -8.4% | -14.0% | -62.8% | 343.2% |